MARGARET WAIT: Open Payments
NPI 1760944599 · BOONEVILLE, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 49 payments from 9 companies in 2025. Trend: 2023 $55 · 2024 $290 · 2025 $864
Food & beverage: $847Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 11 | $189 |
| Verona Pharma, Inc. | 12 | $154 |
| Insmed, Inc. | 6 | $127 |
| GENZYME CORPORATION | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $104 |
| Electromed, Inc. | 4 | $62 |
| Viatris Specialty LLC | 3 | $57 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: Ohtuvayre, NUCALA, DUPIXENT, Arikayce, SMARTVEST, AIRSUPRA, YUPELRI, TRELEGY ELLIPTA.
Industry payments across MS — which companies pay providers there.
